[HTML][HTML] STAT3–BDNF–TrkB signalling promotes alveolar epithelial regeneration after lung injury
…, SA Toulmin, JA Zepp, WJ Zacharias, JB Katzen… - Nature Cell …, 2020 - nature.com
Alveolar epithelial regeneration is essential for recovery from devastating lung diseases.
This process occurs when type II alveolar pneumocytes (AT2 cells) proliferate and …
This process occurs when type II alveolar pneumocytes (AT2 cells) proliferate and …
Microstructured Hydrogels to Guide Self‐Assembly and Function of Lung Alveolospheres
Epithelial cell organoids have increased opportunities to probe questions on tissue
development and disease in vitro and for therapeutic cell transplantation. Despite their potential, …
development and disease in vitro and for therapeutic cell transplantation. Despite their potential, …
[HTML][HTML] Early stage lung cancer detection in systemic sclerosis does not portend survival benefit: a cross sectional study
JB Katzen, K Raparia, R Agrawal, JD Patel… - PloS one, 2015 - journals.plos.org
Background Systemic Sclerosis (SSc) is a rare connective tissue disorder associated with
an increased risk of malignancy including lung cancer. Methods A single center review of all …
an increased risk of malignancy including lung cancer. Methods A single center review of all …
[HTML][HTML] Using selective lung injury to improve murine models of spatially heterogeneous lung diseases
AJ Paris, L Guo, N Dai, JB Katzen, PN Patel… - Plos one, 2019 - journals.plos.org
Many lung diseases, such as the acute respiratory distress syndrome (ARDS), display
significant regional heterogeneity with patches of severely injured tissue adjacent to apparently …
significant regional heterogeneity with patches of severely injured tissue adjacent to apparently …
Emergency department evaluations of non-percutaneous blood or body fluid exposures during cardiopulmonary resuscitation
RC Merchant, JB Katzen, KH Mayer… - Prehospital and disaster …, 2007 - cambridge.org
Introduction:The demography of healthcare workers (HCWs) and non- HCWs seeking medical
care at emergency departments after a non-percutaneous potential exposure to human …
care at emergency departments after a non-percutaneous potential exposure to human …
[HTML][HTML] Centers for Medicare & Medicaid Services' decision on drug-coated balloons: No additional reimbursement despite higher cost and highest levels of scientific …
…, WS Jones, K Rosenfield, BT Katzen… - Vascular …, 2018 - journals.sagepub.com
… Jeremy B Provance … Barry T Katzen – Scientific Advisory Board: Boston Scientific, WL Gore,
Philips Healthcare, GraftWorx. Michael R Jaff – Uncompensated advisor: … Barry T Katzen …
Philips Healthcare, GraftWorx. Michael R Jaff – Uncompensated advisor: … Barry T Katzen …
[HTML][HTML] Quality of life after pharmacomechanical catheter-directed thrombolysis for proximal deep venous thrombosis
…, J Willatt, G Escobar, S Samuels, B Katzen… - Journal of Vascular …, 2020 - Elsevier
Background After deep venous thrombosis (DVT), many patients have impaired quality of life
(QOL). We aimed to assess whether pharmacomechanical catheter-directed thrombolysis (…
(QOL). We aimed to assess whether pharmacomechanical catheter-directed thrombolysis (…
[PDF][PDF] The cellular and physiological basis for lung repair and regeneration: past, present, and future
The respiratory system, which includes the trachea, airways, and distal alveoli, is a complex
multi-cellular organ that intimately links with the cardiovascular system to accomplish gas …
multi-cellular organ that intimately links with the cardiovascular system to accomplish gas …
Disruption of proteostasis causes IRE1 mediated reprogramming of alveolar epithelial cells
J Katzen, L Rodriguez, Y Tomer… - Proceedings of the …, 2022 - National Acad Sciences
Disruption of alveolar type 2 cell (AEC2) protein quality control has been implicated in
chronic lung diseases, including pulmonary fibrosis (PF). We previously reported the in vivo …
chronic lung diseases, including pulmonary fibrosis (PF). We previously reported the in vivo …
Early oseltamivir after hospital admission is associated with shortened hospitalization: a 5-year analysis of oseltamivir timing and clinical outcomes
J Katzen, R Kohn, JL Houk… - Clinical Infectious Diseases, 2019 - academic.oup.com
Background Neuraminidase inhibitors (NAIs) are the only effective therapy for influenza, but
few studies have assessed the impact of early NAI therapy on clinical outcomes or the …
few studies have assessed the impact of early NAI therapy on clinical outcomes or the …